Measuring adherence to practice guidelines for the management of hypertension: An evaluation of the literature

Hypertension

Volumn 44, Issue 5, 2004, Pages 602-608

  Milchak, Jessica L ^a   Carter, Barry L ^a,b   James, Paul A ^b   Ardery, Gail ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Epidemiology; Hypertension, detection and control; Lifestyle; Population

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

BLOOD PRESSURE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; EVALUATION; HEALTH SURVEY; HUMAN; HYPERTENSION; MEASUREMENT; MEDICAL RECORD; METHODOLOGY; PATIENT CARE; PERFORMANCE; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY; VALIDATION PROCESS;

GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; PRACTICE GUIDELINES;

EID: 7244250001     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000144100.29945.5e     Document Type: Short Survey

References (47)

1. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA. 2002; 288:1909-1914.
2. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1:2-4.
3. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? the effect of a consensus statement on the practice of physicians. N Engl J Med. 1989;321: 1306-1311.
4. Worrall G, Chaulk P, Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. Can Med Assoc J. 1997;156:1705-1712.
5. Hayward RS. Clinical practice guidelines on trial. Can Med Assoc J. 1997;156:1725-1727.
6. Gupta L, Ward JE, Hayward RS. Clinical practice guidelines in general practice: a national survey of recall, attitudes and impact. Med J Aust. 1997;166:69-72.
7. Woolf SH. Practice guidelines: a new reality in medicine, III: impact on patient care. Arch Intern Med. 1993;153:2646-2655.
8. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 1977;237:255-261.
9. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1980;140:1280-1285.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1984;144:1045-1057.
11. 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-1038.
12. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
13. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206-1252.
15. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290:199-206.
16. Monane M, Glynn RJ, Gurwitz JH, Bonn RL, Levin R, Avorn J. Trends in medication choices for hypertension in the elderly: the decline of the thiazides. Hypertension. 1995;25:1045-1051.
17. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 1997;278:1745-1748.
18. Clause SL, Hamilton RA. Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines. Ann Pharmacother. 2002;36:1505-1511.
19. Mehta SS, Wilcox CS, Schulman KA. Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP). Am J Hypertens. 1999;12:333-340.
20. Dickerson JE, Garratt CJ, Brown MJ. Management of hypertension in general practice: agreements with and variations from the British Hypertension Society guidelines. J Hum Hypertens. 1995;9:835-839.
21. Asch SM, Kerr EA, Lapuerta P, Law A, McGlynn EA. A new approach for measuring quality of care for women with hypertension. Arch Intern Med. 2001;161:1329-1335.
22. Cuspidi C, Michev I, Lonati L, Vaccarella A, Cristofari M, Garavelli G, Palumbo G, Meani S, Leonetti G, Magrini F, Zanchetti A. Compliance to hypertension guidelines in clinical practice: a multicentre pilot study in Italy. J Hum Hypertens. 2002;16:699-703.
23. Lawler FH, Viviani N. Patient and physician perspectives regarding treatment of diabetes: compliance with practice guidelines. J Fam Pract. 1997;44:369-373.
24. Schuster MA, Asch SM, McGlynn EA, Kerr EA, Hardy AM, Gifford DS. Development of a quality of care measurement system for children and adolescents: methodological considerations and comparisons with a system for adult women. Arch Pediatr Adolesc Med. 1997;151: 1085-1092.
25. Worrall G, Freake D, Kelland J, Pickle A, Keenan T. Care of patients with type II diabetes: a study of family physicians' compliance with clinical practice guidelines. J Fam Pract. 1997;44:374-381.
26. Malone DC, Shaban HM. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia. Ann Pharmacother. 2001; 35:1180-1185.
27. Naiman DJ, Barker LR. Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic. Md Med J. 1999;48: 307-311.
28. Carter BL, Malone DC, Ellis SL, Dombrowski RC. Antihypertensive drug utilization in hypertensive veterans with complex medication profiles. J Clin Hypertens. 2000;2:172-180.
29. Weiss R, Buckley K, Clifford T. Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 1997-2000. Clin Ther. 2002;24:1451-1462.
30. Carter BL, Kriesel HT, Steinkraus L, Knudson R. Antihypertensive drug-prescribing patterns of internists and family physicians. J Fam Pract. 1989;29:257-261.
31. Cloher TP, Whelton PK. Physician approach to the recognition and initial management of hypertension: results of a statewide survey of Maryland physicians. Arch Intern Med. 1986;146:529-533.
32. Henderson SO, Bretsky P, DeQuattro V, Henderson BE. Treatment of hypertension in African Americans and Latinos: the effect of JNC VI on urban prescribing practices. J Clin Hypertens. 2003;5:107-112.
33. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829-837.
34. Siegel D, Lopez J, Meier J, Cunningham F. Changes in the pharmacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of β-blockers and thiazide diuretics. Am J Hypertens. 2001;14:957-962.
35. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281-2286.
36. Nelson CR, Knapp DA. Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians. Hypertension. 2000; 36:600-603.
37. Campbell NR, McAlister FA, Brant R, Levine M, Drouin D, Feldman R, Herman R, Zarnke K. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens. 2003;21:1591-1597.
38. Balas EA. Trends in antihypertensive drug therapy by US office-based physicians. Hypertension. 2001;37:E12.
39. McAlister FA, Teo KK, Laupacis A. A survey of management practices for isolated systolic hypertension. J Am Geriatr Soc. 1997;45:1219-1222.
40. Xu KT, Moloney M, Phillips S. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension. Am J Manag Care. 2003;9: 529-536.
41. Eccles M, Ford GA, Duggan S, Steen N. Are postal questionnaire surveys of reported activity valid? an exploration using general practitioner management of hypertension in older people. Br J Gen Pract. 1999;49:35-38.
42. Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995;85:795-800.
43. McAlister FA, Teo KK, Lewanczuk RZ, Wells C, Montague TJ. Contemporary practice patterns in the management of newly diagnosed hypertension. Can Med Assoc J. 1997;157:23-30.
44. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
45. Olson KK, Autio LA. Measuring quality of care for essential hypertension. Holist Nurs Pract. 2001;15:22-34.
46. James PA, Cowan TM, Graham RP, Jaen CR, Majeroni BA, Schwartz JS. Heart failure in primary care: measuring the quality of care. J Fam Pract. 1999;48:790-798.
47. Milchak JL, Carter BL, Bakris GL, Black HR, Jones DW. Zillich AJ. Selection of explicit criteria for a JNC-7 adherence tool. Am J Hypertens. 2004;15:144A. Abstract.